(PSCH) Invesco S&P SmallCap Health - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E1495 • Health
PSCH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment
The Invesco S&P SmallCap Health Care ETF (PSCH) is an exchange-traded fund (ETF) that tracks the performance of small-capitalization U.S. companies in the health care sector. The fund invests at least 90% of its total assets in the securities of the S&P SmallCap 600 Health Care Index, which is compiled, maintained, and calculated by S&P Dow Jones Indices, LLC. This index is designed to measure the performance of small-cap U.S. healthcare companies, as defined by the Global Industry Classification Standard (GICS).
The ETF provides exposure to a specific segment of the healthcare industry, focusing on smaller companies that may offer growth potential. It is designed for investors seeking targeted exposure to the small-cap healthcare sector within the U.S. equity market.
Additional Sources for PSCH ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PSCH ETF Overview
Market Cap in USD | 147m |
Category | Health |
TER | 0.29% |
IPO / Inception | 2010-04-07 |
PSCH ETF Ratings
Growth Rating | -3.84 |
Fundamental | - |
Dividend Rating | 25.5 |
Rel. Strength | -8.66 |
Analysts | - |
Fair Price Momentum | 36.21 USD |
Fair Price DCF | - |
PSCH Dividends
Dividend Yield 12m | 0.23% |
Yield on Cost 5y | 0.26% |
Annual Growth 5y | 447.72% |
Payout Consistency | 23.8% |
PSCH Growth Ratios
Growth Correlation 3m | -84.6% |
Growth Correlation 12m | 26% |
Growth Correlation 5y | -37.4% |
CAGR 5y | 1.37% |
CAGR/Max DD 5y | 0.03 |
Sharpe Ratio 12m | 0.05 |
Alpha | -10.10 |
Beta | 1.030 |
Volatility | 39.48% |
Current Volume | 13.3k |
Average Volume 20d | 8.4k |
As of April 16, 2025, the stock is trading at USD 39.95 with a total of 13,262 shares traded.
Over the past week, the price has changed by +5.80%, over one month by -6.28%, over three months by -11.68% and over the past year by -2.36%.
Neither. Based on ValueRay Analyses, Invesco S&P SmallCap Health is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.84 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSCH as of April 2025 is 36.21. This means that PSCH is currently overvalued and has a potential downside of -9.36%.
Invesco S&P SmallCap Health has no consensus analysts rating.
According to ValueRays Forecast Model, PSCH Invesco S&P SmallCap Health will be worth about 40.3 in April 2026. The stock is currently trading at 39.95. This means that the stock has a potential upside of +0.8%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 40.3 | 0.8% |